Andoniou C E, Lill N L, Thien C B, Lupher M L, Ota S, Bowtell D D, Scaife R M, Langdon W Y, Band H
Lymphocyte Biology Section, Division of Rheumatology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Mol Cell Biol. 2000 Feb;20(3):851-67. doi: 10.1128/MCB.20.3.851-867.2000.
Fyn is a prototype Src-family tyrosine kinase that plays specific roles in neural development, keratinocyte differentiation, and lymphocyte activation, as well as roles redundant with other Src-family kinases. Similar to other Src-family kinases, efficient regulation of Fyn is achieved through intramolecular binding of its SH3 and SH2 domains to conserved regulatory regions. We have investigated the possibility that the tyrosine kinase regulatory protein Cbl provides a complementary mechanism of Fyn regulation. We show that Cbl overexpression in 293T embryonic kidney and Jurkat T-lymphocyte cells led to a dramatic reduction in the active pool of Fyn; this was seen as a reduction in Fyn autophosphorylation, reduced phosphorylation of in vivo substrates, and inhibition of transcription from a Src-family kinase response element linked to a luciferase reporter. Importantly, a Fyn mutant (FynY528F) relieved of intramolecular repression was still negatively regulated by Cbl. The Cbl-dependent negative regulation of Fyn did not appear to be mediated by inhibition of Fyn kinase activity but was correlated with enhanced protein turnover. Consistent with such a mechanism, elevated levels of Fyn protein were observed in cell lines derived from Cbl(-/-) mice compared to those in wild-type controls. The effects of Cbl on Fyn were not observed when the 70ZCbl mutant protein was analyzed. Taken together, these observations implicate Cbl as a component in the negative regulation of Fyn and potentially other Src-family kinases, especially following kinase activation. These results also suggest that protein degradation may be a general mechanism for Cbl-mediated negative regulation of activated tyrosine kinases.
Fyn是一种典型的Src家族酪氨酸激酶,在神经发育、角质形成细胞分化和淋巴细胞激活中发挥特定作用,同时也具有与其他Src家族激酶冗余的功能。与其他Src家族激酶类似,Fyn的有效调节是通过其SH3和SH2结构域与保守调节区域的分子内结合来实现的。我们研究了酪氨酸激酶调节蛋白Cbl是否提供了一种Fyn调节的互补机制。我们发现,在293T胚胎肾细胞和Jurkat T淋巴细胞中过表达Cbl会导致Fyn的活性池显著减少;这表现为Fyn自身磷酸化减少、体内底物磷酸化减少以及与荧光素酶报告基因相连的Src家族激酶反应元件的转录受到抑制。重要的是,一种解除了分子内抑制的Fyn突变体(FynY528F)仍然受到Cbl的负调节。Cbl对Fyn的负调节似乎不是通过抑制Fyn激酶活性介导的,而是与蛋白质周转增强相关。与这种机制一致,与野生型对照相比,在源自Cbl(-/-)小鼠的细胞系中观察到Fyn蛋白水平升高。分析70ZCbl突变蛋白时未观察到Cbl对Fyn的影响。综上所述,这些观察结果表明Cbl是Fyn以及潜在的其他Src家族激酶负调节的一个组成部分,特别是在激酶激活之后。这些结果还表明,蛋白质降解可能是Cbl介导的对活化酪氨酸激酶负调节的一种普遍机制。